New Market Report Now Available: InDex Pharmaceuticals AB -...
The company has developed two products based on its technology platform. Its products include Kappaproct, which is being developed in Phase III clinical trials for the treatment of steroid resistant ulcerative colitis; and DIMS 9054, a preclinical potential treatment for steroid resistant asthma.
Join the discussion below, or Read more at PR-inside.com.
#1 Jun 23, 2013
Nigeria navy recruitment service form is out for more detail call 08146558553. Please don't miss this opportunity.
#2 Jun 23, 2013
Nigeria custom recruitment service is presently going on for more information contact 08146558553.
Add your comments below
|Study Finds No Tie Between Acne Drug Accutane a... (Mar '13)||May 7||Dan||11|
|Inflammatory bowel disease in kids under 5 on r...||Apr '17||Buddy||1|
|Inflammatory bowel disease in kids under 5 on r...||Apr '17||MMR||1|
|Genome study identifies risk genes in African A... (Oct '16)||Oct '16||Oh No You Di-nt||3|
|Nonpathogenic Viruses Transferred During Fecal ... (Mar '16)||Mar '16||Rafy||1|
|New treatment could help those with Crohn's, co... (Oct '13)||Jun '14||question||12|
|FDA Approves Uceris (Budesonide) for Patients W... (Jan '13)||Oct '13||Chuck||2|
Find what you want!
Search Ulcerative Colitis Forum Now
Copyright © 2017 Topix LLC